Crystalline Management’s Meridian Bioscience Inc VIVO Stock Holding History

Crystalline Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-244,453	Closed	-$8.12M	–	148
2022 Q4	$8.12M	Buy	+244,453	New	+$7.87M	4.08%	3

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Crystalline Management's VIVO Position: Q1 2023 in Review

Crystalline Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 244,453 shares — an estimated $8.12M sold.

Crystalline Management first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $8.12M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Crystalline Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Crystalline Management sold 244,453 Meridian Bioscience Inc shares in Q1 2023, an estimated $8.12M.
Crystalline Management first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
Crystalline Management's Meridian Bioscience Inc position peaked at $8.12M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Crystalline Management's 13F filing for Q1 2023, filed 9 May 2023.